Nutraceutical Protocols: 

Diabetic Peripheral Neuropathy (DPN)

There is good evidence for the beneficial use of nutraceuticals in the management of pain associated with DPN. Multiple nutraceuticals offer save and affordable benefits through different mechanisms which may be additive or potentially synergistic. 

 

See:  

Nutraceutical Protocols: 

 

  

Key to Links:

  • Grey text – handout
  • Red text – another page on this website
  • Blue text – Journal publication

Definitions and Terms Related to Pain

 

NUTRACEUTICAL PROTOCOLS:

Diabetic Peripheral Neuropathy (DPN)

   Pathophysiology Targeted:

  1. Oxidative stress
  2. Neuroinflammation
  3. Mitochondrial Dysfunction
  4. Nerve fiber degeneration, impaired nerve growth factor

Evidence Summary:

The ASPN SWEET Guidelines note that alpha-lipoic acid and acetyl-L-carnitine have been used for DPN with success, though high-grade comparative evidence is lacking.[1] A systematic review supports the use of alpha-lipoic acid, acetyl-L-carnitine, and vitamin D for DPN.[2] PEA has demonstrated neuroprotective effects in DPN models, reducing mechanical and thermal hyperalgesia while decreasing mast cell activation and nerve growth factor expression.[3]

SUMMARY

Agent

Dosing Protocol

Mechanism/Rationale

References

Alpha-Lipoic Acid (ALA)

600 mg once daily (oral); IV loading 600 mg × 3 weeks if available

Reduces oxidative stress; improves nerve conduction; SYDNEY 2 trial showed symptom improvement

[1], [2], [3]

Palmitoylethanolamide (PEA)

600 mg BID × 3 weeks → 600 mg QD

Reduces neuroinflammation, mast cell activation; neuroprotective via PPAR-α

[4], [5], [6]

Acetyl-L-Carnitine (ALC)

500–1000 mg BID

Supports nerve regeneration; improves vibration perception

[1], [3], [7]

Magnesium

400–500 mg daily (glycinate)

NMDA receptor modulation; enhances opioid analgesia

34

Vitamin D3

Dose to 25(OH)D 40–60 ng/mL

Modulates opioid signaling; systematic review supports use in DPN

[3]]

Melatonin

3–10 mg QHS

NLRP3 inflammasome inhibition; opioid synergy

34

CoQ10

200–400 mg daily

Addresses mitochondrial dysfunction; preliminary evidence in DPN

[8]

Omega-3 (EPA/DHA)

1–2 g daily

Anti-inflammatory; preliminary evidence in DPN symptoms

[8]

ALA + PEA Combination: A clinical study showed that oral ALA 600 mg/day ± PEA 600 mg/day significantly decreased Neuropathy Symptoms Score (5.4 → 1.7) with mean time to symptom relief of 18.4 days. Higher HDL-cholesterol and better renal function predicted faster response.[5]

Protocol Notes:

  1. Optimize vitamin D and magnesium at baseline
  2. Start with ALA + PEA as foundation given direct clinical evidence in DPN
  3. Add ALC for patients with significant sensory symptoms
  4. Consider IV ALA loading for severe symptoms (more consistent benefit than oral in some studies)[9]
  5. Monitor HbA1c; glycemic control remains essential, particularly in Type 1 DM[1]

Considerations

  1. Many DPN patients have comorbid conditions of pain superimposed on their DPN and are on chronic opioid therapy. Consideration should be given to the use of the nutraceuticals that have shown potential for enhancing opioid analgesia in addition to those nutraceuticals specifically targeted at managing fibromyalgia symptoms. (See:  Nutraceutical Approaches to Complement Chronic Opioid Therapy
  2. The current nutraceutical recommendations reviewed here are diagnostic condition-centric and thus generally directed at most patients diagnosed with DPN. However, alternative consideration should be given to personalizing nutraceutical choices based on individualized clinical profiling that provide insights into the relative roles of Systemic Inflammation (SI), Neuroinflammation (NI), Oxidative Stress (OS), and Mitochondrial Dysfunction (MD) and the importance of their impact on the patient’s pain processing and subsequent pain experience.  Such personalizing of nutraceutical choices may be more likely to provide greater success and symptom management of DPN.

—

References

  1. A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET. Sayed D, Deer TR, Hagedorn JM, et al. Journal of Pain Research. 2024;17:1461-1501. doi:10.2147/JPR.S451006.
  2. The Role of Diet and Non-Pharmacologic Supplements in the Treatment of Chronic Neuropathic Pain: A Systematic Review. Frediani JK, Lal AA, Kim E, et al. Pain Practice : The Official Journal of World Institute of Pain. 2024;24(1):186-210. doi:10.1111/papr.13291.
  3. The Neuroprotective Effects of Micronized PEA (PEA-m) Formulation on Diabetic Peripheral Neuropathy in Mice. Impellizzeri D, Peritore AF, Cordaro M, et al. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 2019;33(10):11364-11380. doi:10.1096/fj.201900538R.
  4. Pathogenetic Treatments for Diabetic Peripheral Neuropathy. Ziegler D. Diabetes Research and Clinical Practice. 2023;206 Suppl 1:110764. doi:10.1016/j.diabres.2023.110764.
  5. Biomarkers of Response to Alpha-Lipoic Acid ± palmitoiletanolamide Treatment in Patients With Diabetes and Symptoms of Peripheral Neuropathy. Pieralice S, Vari R, Minutolo A, et al. Endocrine. 2019;66(2):178-184. doi:10.1007/s12020-019-01917-w.
  6. Meta-Analysis of Palmitoylethanolamide in Pain Management: Addressing Literature Gaps and Enhancing Understanding. Viña I, López-Moreno M. Nutrition Reviews. 2025;83(7):e1604-e1618. doi:10.1093/nutrit/nuae203.
  7. Nutraceutical Approach to Peripheral Neuropathies: Evidence From Clinical Trials. Mostacci B, Liguori R, Cicero AF. Current Drug Metabolism. 2018;19(5):460-468. doi:10.2174/1389200218666171031145419.
  8. Dietary and Nutritional Supplementation for Painful Diabetic Neuropathy: A Narrative Review. Apergi K, Papanas N. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association. 2023;131(12):646-655. doi:10.1055/a-2188-1745.
  9. Diabetic Peripheral Neuropathy: Prevention and Treatment. Bragg S, Marrison ST, Haley S. American Family Physician. 2024;109(3):226-232.
  10. Nociplastic Pain: Towards an Understanding of Prevalent Pain Conditions. Fitzcharles MA, Cohen SP, Clauw DJ, et al. Lancet (London, England). 2021;397(10289):2098-2110. doi:10.1016/S0140-6736(21)00392-5.
  11. Review of Nutritional Approaches to Fibromyalgia. Kadayifci FZ, Bradley MJ, Onat AM, Shi HN, Zheng S. Nutrition Reviews. 2022;80(12):2260-2274. doi:10.1093/nutrit/nuac036.
  12. Fibromyalgia and Nutrition: Therapeutic Possibilities?. Bjørklund G, Dadar M, Chirumbolo S, Aaseth J. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2018;103:531-538. doi:10.1016/j.biopha.2018.04.056.
  13. Serum Magnesium Levels and Their Association With Sleep Quality and Disease Severity in Fibromyalgia Syndrome: An Observational Cross-Sectional Study. Alisik T, Reis Altan YC, Olkay SG, Sahingoz Bakirci E. Medicine. 2025;104(29):e43446. doi:10.1097/MD.0000000000043446.
  14. Is Magnesium Citrate Treatment Effective on Pain, Clinical Parameters and Functional Status in Patients With Fibromyalgia?. Bagis S, Karabiber M, As I, et al. Rheumatology International. 2013;33(1):167-72. doi:10.1007/s00296-011-2334-8.
  15. Psychological and Sleep Effects of Tryptophan and Magnesium-Enriched Mediterranean Diet in Women With Fibromyalgia. Martínez-Rodríguez A, Rubio-Arias JÁ, Ramos-Campo DJ, et al. International Journal of Environmental Research and Public Health. 2020;17(7):E2227. doi:10.3390/ijerph17072227.
  16. Targeted Treatment of Age-Related Fibromyalgia With Supplemental Coenzyme Q10. Hargreaves IP, Mantle D. Advances in Experimental Medicine and Biology. 2021;1286:77-85. doi:10.1007/978-3-030-55035-6_5.
  17. Bioactive Compounds for Fibromyalgia-Like Symptoms: A Narrative Review and Future Perspectives. Shen CL, Schuck A, Tompkins C, Dunn DM, Neugebauer V. International Journal of Environmental Research and Public Health. 2022;19(7):4148. doi:10.3390/ijerph19074148.
  18. Nutritional Intervention in Chronic Pain: An Innovative Way of Targeting Central Nervous System Sensitization?. Nijs J, Tumkaya Yilmaz S, Elma Ö, et al. Expert Opinion on Therapeutic Targets. 2020;24(8):793-803. doi:10.1080/14728222.2020.1784142.
  19. Is the Gut Microbiome of Importance in Fibromyalgia? A Critical Review of Emerging Evidence. Shtrozberg S, Bazzichi L, Sarzi-Puttini P, Aloush V, Ablin JN. Clinical and Experimental Rheumatology. 2025;43(6):990-998. doi:10.55563/clinexprheumatol/pmajsv.
  20. Alpha-Lipoic Acid, Palmitoylethanolamide, Myrrh, and Oxygen-Ozone Therapy Improve Pharmacological Therapy in Acute Painful Lumbosacral Radiculopathy Due to Herniated Disc. Latini E, Bonasia G, Petroselli L, et al. Pain Physician. 2023;26(4):E363-E373.
  21. Curcumin Alleviates Lumbar Radiculopathy by Reducing Neuroinflammation, Oxidative Stress and Nociceptive Factors. Xiao L, Ding M, Fernandez A, et al. European Cells & Materials. 2017;33:279-293. doi:10.22203/eCM.v033a21.
  22. Efficacy of Percutaneous Laser Disc Decompression (PLDD) Combined With an Oral Food Supplement for Lumbar Disc Herniation. Gazzeri R, Leoni MLG, Occhigrossi F. Journal of Clinical Medicine. 2024;13(17):5049. doi:10.3390/jcm13175049.
  23. Natural Products for Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Potentials. Wu Z, Chen J, Luo W, Kuang T. Frontiers in Pharmacology. 2025;16:1605764. doi:10.3389/fphar.2025.1605764.
  24. Efficacy and Safety of Magnesium for the Management of Chronic Pain in Adults: A Systematic Review. Park R, Ho AM, Pickering G, et al. Anesthesia and Analgesia. 2020;131(3):764-775. doi:10.1213/ANE.0000000000004673.
  25. A Meta-Analysis of the Analgesic Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation for Inflammatory Joint Pain. Goldberg RJ, Katz J. Pain. 2007;129(1-2):210-23. doi:10.1016/j.pain.2007.01.020.
  26. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals. Kang L, Zhang H, Jia C, Zhang R, Shen C. Frontiers in Pharmacology. 2022;13:956355. doi:10.3389/fphar.2022.956355.
  27. Conditional Recommendations for Specific Dietary Ingredients as an Approach to Chronic Musculoskeletal Pain: Evidence-Based Decision Aid for Health Care Providers, Participants, and Policy Makers. Boyd C, Crawford C, Berry K, Deuster P. Pain Medicine (Malden, Mass.). 2019;20(7):1430-1448. doi:10.1093/pm/pnz051.
  28. Which Supplements Can I Recommend to My Osteoarthritis Patients?. Liu X, Eyles J, McLachlan AJ, Mobasheri A. Rheumatology (Oxford, England). 2018;57(suppl_4):iv75-iv87. doi:10.1093/rheumatology/key005.
  29. Dietary Supplements for Treating Osteoarthritis: A Systematic Review and Meta-Analysis. Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. British Journal of Sports Medicine. 2018;52(3):167-175. doi:10.1136/bjsports-2016-097333.
  30. A Complex of Three Natural Anti-Inflammatory Agents Provides Relief of Osteoarthritis Pain. Conrozier T, Mathieu P, Bonjean M, et al. Alternative Therapies in Health and Medicine. 2014;20 Suppl 1:32-7.
  31. Synthetic Secoisolariciresinol Diglucoside Attenuates Established Pain, Oxidative Stress and Neuroinflammation in a Rodent Model of Painful Radiculopathy. Kartha S, Weisshaar CL, Pietrofesa RA, Christofidou-Solomidou M, Winkelstein BA. Antioxidants (Basel, Switzerland). 2020;9(12):E1209. doi:10.3390/antiox9121209.
  32. Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-alpha-mediated Mechanism. Di Cesare Mannelli L, D’Agostino G, Pacini A, et al. Mediators of Inflammation. 2013;2013:328797. doi:10.1155/2013/328797.
  33. Non-Drug Pain Relievers Active on Non-Opioid Pain Mechanisms. Marchesi N, Govoni S, Allegri M. Pain Practice : The Official Journal of World Institute of Pain. 2022;22(2):255-275. doi:10.1111/papr.13073.
  34. Nutraceutical Interactions with Opioid Pain Processing

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

 

 

.